These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19387321)

  • 1. A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
    Narita M; Hatano E; Ikai I; Miyagawa-Hayashino A; Yanagida A; Nagata H; Asechi H; Taura K; Uemoto S
    Ann Surg; 2009 May; 249(5):806-13. PubMed ID: 19387321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome.
    Sugita H; Nakanuma S; Munesue S; Ishikawa T; Tokoro T; Takei R; Okazaki M; Kato K; Takada S; Makino I; Ozaki N; Yamamoto Y; Yagi S
    J Gastroenterol Hepatol; 2024 Jul; 39(7):1413-1421. PubMed ID: 38348885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
    Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
    Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver injury due to chemotherapy-induced sinusoidal obstruction syndrome is associated with sinusoidal capillarization.
    Narita M; Oussoultzoglou E; Chenard MP; Fuchshuber P; Rather M; Rosso E; Addeo P; Jaeck D; Bachellier P
    Ann Surg Oncol; 2012 Jul; 19(7):2230-7. PubMed ID: 22402811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced Sinusoidal Injury (CSI) score: a novel histologic assessment of chemotherapy-related hepatic sinusoidal injury in patients with colorectal liver metastasis.
    Stevenson HL; Prats MM; Sasatomi E
    BMC Cancer; 2017 Jan; 17(1):35. PubMed ID: 28061766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phosphodiesterase III inhibitor protects rat liver from sinusoidal obstruction syndrome through heme oxygenase-1 induction.
    Kobayashi T
    Ann Surg; 2010 Apr; 251(4):780; author reply 780. PubMed ID: 20224351
    [No Abstract]   [Full Text] [Related]  

  • 7. Sinusoidal obstruction syndrome in the animal model: influence on liver surgery.
    Jafari A; Wehner S; Kalff JC; Manekeller S
    Langenbecks Arch Surg; 2017 Feb; 402(1):115-122. PubMed ID: 27585678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The flavonoid monoHER prevents monocrotaline-induced hepatic sinusoidal injury in rats.
    Ezzat T; van den Broek MA; Davies N; Dejong CH; Bast A; Malagó M; Dhar DK; Olde Damink SW
    J Surg Oncol; 2012 Jul; 106(1):72-8. PubMed ID: 22287334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic regeneration is decreased in a rat model of sinusoidal obstruction syndrome.
    Schiffer E; Frossard JL; Rubbia-Brandt L; Mentha G; Pastor CM
    J Surg Oncol; 2009 Jun; 99(7):439-46. PubMed ID: 19353590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olprinone attenuates excessive shear stress through up-regulation of endothelial nitric oxide synthase in a rat excessive hepatectomy model.
    Yamanaka K; Hatano E; Narita M; Kitamura K; Yanagida A; Asechi H; Nagata H; Taura K; Nitta T; Uemoto S
    Liver Transpl; 2011 Jan; 17(1):60-9. PubMed ID: 21254346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorafenib attenuates monocrotaline-induced sinusoidal obstruction syndrome in rats through suppression of JNK and MMP-9.
    Nakamura K; Hatano E; Narita M; Miyagawa-Hayashino A; Koyama Y; Nagata H; Iwaisako K; Taura K; Uemoto S
    J Hepatol; 2012 Nov; 57(5):1037-43. PubMed ID: 22796153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases.
    Morris-Stiff G; Tan YM; Vauthey JN
    Eur J Surg Oncol; 2008 Jun; 34(6):609-14. PubMed ID: 17764887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.
    Vreuls CP; Van Den Broek MA; Winstanley A; Koek GH; Wisse E; Dejong CH; Olde Damink SW; Bosman FT; Driessen A
    Histopathology; 2012 Aug; 61(2):314-8. PubMed ID: 22571348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regorafenib suppresses sinusoidal obstruction syndrome in rats.
    Okuno M; Hatano E; Nakamura K; Miyagawa-Hayashino A; Kasai Y; Nishio T; Seo S; Taura K; Uemoto S
    J Surg Res; 2015 Feb; 193(2):693-703. PubMed ID: 25266603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of pre-surgical chemotherapy on liver parenchyma and post-surgical outcome of patients subjected to hepatectomy due to colorectal carcinoma metastases].
    Gómez-Ramírez J; Martín-Pérez E; Amat CG; Sanz IG; Bermejo E; Rodríguez A; Larrañaga E
    Cir Esp; 2010 Dec; 88(6):404-12. PubMed ID: 20971458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble thrombomodulin attenuates sinusoidal obstruction syndrome in rat through suppression of high mobility group box 1.
    Nakamura K; Hatano E; Miyagawa-Hayashino A; Okuno M; Koyama Y; Narita M; Seo S; Taura K; Uemoto S
    Liver Int; 2014 Nov; 34(10):1473-87. PubMed ID: 24498917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases.
    van den Broek MA; Vreuls CP; Winstanley A; Jansen RL; van Bijnen AA; Dello SA; Bemelmans MH; Dejong CH; Driessen A; Olde Damink SW
    Ann Surg Oncol; 2013 May; 20(5):1462-9. PubMed ID: 23463086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic volume may be a useful indicator of the protective effect of bevacizumab against oxaliplatin-induced hepatic sinusoidal obstruction syndrome.
    Imai K; Emi Y; Iyama KI; Beppu T; Ogata Y; Kakeji Y; Samura H; Oki E; Akagi Y; Maehara Y; Baba H;
    Eur J Surg Oncol; 2014 May; 40(5):559-566. PubMed ID: 24388740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection.
    Duwe G; Knitter S; Pesthy S; Beierle AS; Bahra M; Schmelzle M; Schmuck RB; Lohneis P; Raschzok N; Öllinger R; Sinn M; Struecker B; Sauer IM; Pratschke J; Andreou A
    Eur J Surg Oncol; 2017 Sep; 43(9):1668-1681. PubMed ID: 28599872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of chemotherapy-induced hepatic injury and their implications for patients undergoing liver resection for colorectal liver metastases.
    Khan AZ; Morris-Stiff G; Makuuchi M
    J Hepatobiliary Pancreat Surg; 2009; 16(2):137-44. PubMed ID: 19093069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.